Vanda Pharmaceuticals buy BiotechBee
Start price
24.12.23
/
60%
€3.70
Target price
31.08.25
€5.00
Performance (%)
20.00%
End price
14.12.24
€4.44
Summary
This prediction ended on 14.12.24 with a price of €4.44. The prediction had a final performance of 20.00%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vanda Pharmaceuticals | 0.000% | 0.000% | 49.061% |
| iShares Core DAX® | -1.875% | 2.861% | 18.863% |
| iShares Nasdaq 100 | -2.177% | 0.048% | 3.956% |
| iShares Nikkei 225® | -0.867% | 6.987% | 21.062% |
| iShares S&P 500 | -1.253% | 1.248% | 2.246% |
According to BiotechBee what are the pros and cons of Vanda Pharmaceuticals for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Buy mit Kursziel 5,0
In the thread Trading Vanda Pharmaceuticals
Buy beendet

